Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
INR 3129.0
(0.07%)
INR 3129.0
(0.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 46.75 Billion INR | -21.98% |
| 2022 | 67.29 Billion INR | 14.41% |
| 2021 | 58.81 Billion INR | 4.08% |
| 2020 | 56.5 Billion INR | 2.23% |
| 2019 | 55.27 Billion INR | 7.54% |
| 2018 | 51.4 Billion INR | 25.97% |
| 2017 | 40.8 Billion INR | 7.85% |
| 2016 | 37.83 Billion INR | -22.33% |
| 2015 | 48.71 Billion INR | 56.93% |
| 2014 | 31.04 Billion INR | 13.63% |
| 2013 | 27.31 Billion INR | 31.3% |
| 2012 | 20.8 Billion INR | 28.98% |
| 2011 | 16.13 Billion INR | 13.16% |
| 2010 | 14.25 Billion INR | 5.98% |
| 2009 | 13.45 Billion INR | 22.79% |
| 2008 | 10.95 Billion INR | 5.89% |
| 2007 | 10.34 Billion INR | 22.39% |
| 2006 | 8.45 Billion INR | 40.31% |
| 2005 | 6.02 Billion INR | 69.84% |
| 2004 | 3.54 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 14.18 Billion INR | 2.98% |
| 2024 Q2 | 21.53 Billion INR | 3.67% |
| 2023 Q4 | 13.77 Billion INR | -30.94% |
| 2023 FY | 52.5 Billion INR | -21.98% |
| 2023 Q2 | 19.68 Billion INR | 3.69% |
| 2023 Q3 | 19.94 Billion INR | 1.32% |
| 2023 Q1 | 18.98 Billion INR | 8.58% |
| 2022 Q4 | 17.48 Billion INR | 1.1% |
| 2022 Q2 | 16.2 Billion INR | -0.74% |
| 2022 FY | 67.29 Billion INR | 14.41% |
| 2022 Q1 | 16.32 Billion INR | 17.64% |
| 2022 Q3 | 17.29 Billion INR | 6.73% |
| 2021 FY | 58.81 Billion INR | 4.08% |
| 2021 Q4 | 13.87 Billion INR | -4.59% |
| 2021 Q2 | 15.08 Billion INR | -1.57% |
| 2021 Q3 | 14.54 Billion INR | -3.58% |
| 2021 Q1 | 15.32 Billion INR | 15.11% |
| 2020 Q1 | 14.79 Billion INR | 13.9% |
| 2020 FY | 56.5 Billion INR | 2.23% |
| 2020 Q2 | 14.31 Billion INR | -3.25% |
| 2020 Q3 | 14.1 Billion INR | -1.47% |
| 2020 Q4 | 13.3 Billion INR | -5.61% |
| 2019 Q1 | 14.17 Billion INR | 19.46% |
| 2019 Q2 | 14.3 Billion INR | 0.92% |
| 2019 Q3 | 13.82 Billion INR | -3.36% |
| 2019 Q4 | 12.98 Billion INR | -6.04% |
| 2019 FY | 55.27 Billion INR | 7.54% |
| 2018 Q1 | 12.76 Billion INR | 4.85% |
| 2018 Q3 | 13.68 Billion INR | 4.43% |
| 2018 FY | 51.4 Billion INR | 25.97% |
| 2018 Q2 | 13.1 Billion INR | 2.66% |
| 2018 Q4 | 11.86 Billion INR | -13.29% |
| 2017 Q2 | 9.83 Billion INR | 3.8% |
| 2017 Q4 | 12.17 Billion INR | 15.25% |
| 2017 Q3 | 10.56 Billion INR | 7.43% |
| 2017 FY | 40.8 Billion INR | 7.85% |
| 2017 Q1 | 9.47 Billion INR | 6.29% |
| 2016 Q1 | 10.7 Billion INR | 0.38% |
| 2016 FY | 37.83 Billion INR | -22.33% |
| 2016 Q4 | 8.91 Billion INR | -6.11% |
| 2016 Q3 | 9.49 Billion INR | -5.57% |
| 2016 Q2 | 10.05 Billion INR | -6.07% |
| 2015 Q4 | 10.66 Billion INR | -6.74% |
| 2015 FY | 48.71 Billion INR | 56.93% |
| 2015 Q1 | 14.68 Billion INR | 107.57% |
| 2015 Q2 | 12.79 Billion INR | -12.87% |
| 2015 Q3 | 11.43 Billion INR | -10.63% |
| 2014 Q4 | 7.07 Billion INR | -9.79% |
| 2014 FY | 31.04 Billion INR | 13.63% |
| 2014 Q2 | 8.22 Billion INR | 3.92% |
| 2014 Q1 | 7.91 Billion INR | -4.22% |
| 2014 Q3 | 7.84 Billion INR | -4.62% |
| 2013 Q4 | 8.25 Billion INR | 22.89% |
| 2013 Q1 | 5.99 Billion INR | 16.81% |
| 2013 FY | 27.31 Billion INR | 31.3% |
| 2013 Q2 | 6.35 Billion INR | 6.01% |
| 2013 Q3 | 6.72 Billion INR | 5.83% |
| 2012 Q1 | 5.16 Billion INR | 64.88% |
| 2012 Q2 | 5.3 Billion INR | 2.71% |
| 2012 Q3 | 5.21 Billion INR | -1.52% |
| 2012 Q4 | 5.12 Billion INR | -1.75% |
| 2012 FY | 20.8 Billion INR | 28.98% |
| 2011 FY | 16.13 Billion INR | 13.16% |
| 2011 Q3 | 4.51 Billion INR | 0.0% |
| 2011 Q4 | 3.12 Billion INR | -30.64% |
| 2010 FY | 14.25 Billion INR | 5.98% |
| 2009 FY | 13.45 Billion INR | 22.79% |
| 2008 FY | 10.95 Billion INR | 5.89% |
| 2007 FY | 10.34 Billion INR | 22.39% |
| 2006 FY | 8.45 Billion INR | 40.31% |
| 2005 FY | 6.02 Billion INR | 69.84% |
| 2004 FY | 3.54 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -74.593% |
| Hester Biosciences Limited | 1.27 Billion INR | -3571.126% |
| Aarti Drugs Limited | 8.31 Billion INR | -462.244% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -701.826% |
| Albert David Limited | 1.4 Billion INR | -3220.626% |
| Alembic Limited | 1 Billion INR | -4575.23% |
| Alkem Laboratories Limited | 52.29 Billion INR | 10.593% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -10241.035% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -3076.866% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -372616.62% |
| Brooks Laboratories Limited | 65.62 Million INR | -71154.648% |
| Eris Lifesciences Limited | 10.42 Billion INR | -348.434% |
| FDC Limited | 6.58 Billion INR | -609.927% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -276.074% |
| Gufic Biosciences Limited | 4.07 Billion INR | -1047.775% |
| Hikal Limited | 5.95 Billion INR | -684.782% |
| Ind-Swift Limited | 2.17 Billion INR | -2052.204% |
| Innova Captab Limited | 3.46 Billion INR | -1249.635% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -890.81% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -7064.881% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -138.035% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -2378.04% |
| Lupin Limited | 125.09 Billion INR | 62.623% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -6664.724% |
| Medico Remedies Limited | 262.14 Million INR | -17736.494% |
| Morepen Laboratories Limited | 6.16 Billion INR | -658.889% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -869.407% |
| Orchid Pharma Limited | 2.32 Billion INR | -1915.138% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -708.754% |
| RPG Life Sciences Limited | 2.48 Billion INR | -1783.097% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -7435.702% |
| Sigachi Industries Limited | 2 Billion INR | -2235.199% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 2923.679% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -1033.985% |
| Themis Medicare Limited | 2.42 Billion INR | -1832.114% |
| Unichem Laboratories Limited | 4.86 Billion INR | -861.109% |
| Vaishali Pharma Limited | 90.32 Million INR | -51666.77% |
| Wanbury Limited | 1.73 Billion INR | -2601.73% |
| Windlas Biotech Limited | 1.33 Billion INR | -3392.478% |
| ZIM Laboratories Limited | 1.26 Billion INR | -3588.028% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -1031.257% |
| Ipca Laboratories Limited | 48.58 Billion INR | 3.76% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 81.911% |
| Venus Remedies Limited | 2.18 Billion INR | -2042.29% |
| Sakar Healthcare Limited | 699.58 Million INR | -6583.577% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 57.316% |
| Divi's Laboratories Limited | 32.44 Billion INR | -44.135% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -651.399% |
| Mankind Pharma Limited | 42.19 Billion INR | -10.807% |
| Sequent Scientific Limited | 2.97 Billion INR | -1469.706% |
| Laurus Labs Limited | 15.44 Billion INR | -202.662% |
| Neuland Laboratories Limited | 8.24 Billion INR | -466.904% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -206.426% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 32.569% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 62.657% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -2132.878% |
| Wockhardt Limited | 7.72 Billion INR | -505.665% |
| Bal Pharma Limited | 770.19 Million INR | -5970.839% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 71.421% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -1165.272% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -8736.537% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -407.873% |
| Shilpa Medicare Limited | 3.56 Billion INR | -1212.708% |
| Valiant Laboratories Limited | 138.02 Million INR | -33774.983% |
| Ajanta Pharma Limited | 21.06 Billion INR | -121.977% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -41267.525% |
| Granules India Limited | 16.79 Billion INR | -178.329% |
| Medicamen Biotech Limited | 495.49 Million INR | -9336.483% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -8256.935% |
| Piramal Enterprises Limited | 8.04 Billion INR | -481.32% |
| NATCO Pharma Limited | 25.73 Billion INR | -81.681% |
| Suven Life Sciences Limited | -200.79 Million INR | 23385.856% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 43096.404% |
| Strides Pharma Science Limited | 14.38 Billion INR | -224.972% |
| Indoco Remedies Limited | 8.04 Billion INR | -481.342% |
| Alpa Laboratories Limited | 188.89 Million INR | -24653.064% |
| Lasa Supergenerics Limited | 121.02 Million INR | -38532.819% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -11856.371% |